feed,title,long_url,short_url
ðŸ’°Barrons,Biotech Is Ripe for M&A. These May Be the Next Buy Targets.,https://barrons.com/articles/biotech-acquisitions-immunocare-blueprint-syndax-a27b9a1b?mod=RTA,https://da.gd/cJRD9d
